Video Experimental Relacionado
Updated: Jan 8, 2026
09:38
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
14.3K
Microsferas bioinspiradas de captura de fibrina permiten la formación de coágulos suprafisiológicos bajo hemostasia a
Yuanyuan Ding1, Ting Wang2, Jing Li1
1National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, Sichuan, China.
Advanced healthcare materials
|December 19, 2025
Resumen
Las nuevas microsferas de gelatina dopadas con hidroxiapatita detienen rápidamente las hemorragias graves al formar rápidamente coágulos estables. Estos agentes hemostáticos avanzados prometen para la atención de emergencias al mejorar la estabilidad del coágulo y reducir la pérdida de sangre.
Área de la Ciencia:
- Ciencia de Biomateriales
- Investigación en Hemostasia
- Desarrollo de Dispositivos Médicos
Sus antecedentes:
- La hemostasia eficaz en hemorragias de alta presión es un desafío para los agentes convencionales.
- La incapacidad de secuestrar rápidamente la fibrina y formar coágulos estables limita los tratamientos actuales.
Objetivo del estudio:
- Desarrollar microsferas de gelatina dopadas con hidroxiapatita (HAp) (GHMPs-10) para mejorar la hemostasia.
- Investigar la capacidad de GHMPs-10 para acelerar la coagulación y estabilizar los coágulos en hemorragias graves.
Principales métodos:
- Fabricación de microsferas de gelatina dopadas con HAp (GHMPs-10).
- Evaluación in vitro del reclutamiento de fibrinógeno y la formación de coágulos.
- Medición de la captación de fluidos in vitro y la expansión de las microsferas.
- Pruebas de presión de ruptura in vitro.
- Evaluación in vivo en múltiples modelos animales para la eficacia de la hemostasia.
Principales resultados:
- GHMPs-10 facilitó el reclutamiento rápido de fibrinógeno y el ensamblaje robusto de la red de fibrina.
- La expansión de las microsferas (≈718%) concentró los factores de coagulación y ocluyó mecánicamente el sitio.
- GHMPs-10 demostró una alta resistencia a la presión de ruptura (≈191,5 mmHg).
- Reducción significativa del tiempo de hemostasia y la pérdida de sangre en comparación con agentes comerciales en modelos animales.
Conclusiones:
- GHMPs-10 inicia eficazmente la coagulación y concentra los componentes sanguíneos.
- Las microsferas forman coágulos de hidrogel mecánicamente robustos para una hemostasia rápida.
- Estas microsferas de captura de fibrinógeno representan un candidato prometedor para la traslación clínica en hemostasia de emergencia.
Videos de Conceptos Relacionados
01:16Clot Retraction and Fibrinolysis
8.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.3K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
11.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.8K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
01:22Formation of the Platelet Plug
8.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.6K
01:05Introduction to Hemostasis
13.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.0K
01:09Coagulation
9.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.5K